Patent details

EP2167128 Title: ENGINEERED ANTI-ALPHA V- INTEGRIN HYBRID ANTIBODIES

  • Data
  • Documents

Basic Information

Publication number:
EP2167128
PCT Application Number:
PCT/EP/2008/005852
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087848347
PCT Publication Number:
WO/2009/010290
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ENGINEERED ANTI-ALPHA V- INTEGRIN HYBRID ANTIBODIES
French Title of Invention:
ANTICORPS HYBRIDES MODIFIÉS DIRIGÉS CONTRE L'INTÉGRINE ALPHA V
German Title of Invention:
GENTECHNISCH HERGESTELLTE ANTI-ALPHA-V-INTEGRIN-HYBRIDANTIKÖRPER
SPC Number:

Dates

Filing date:
17/07/2008
Grant date:
24/10/2012
EP Publication Date:
24/10/2012
PCT Publication Date:
22/01/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/03/2010
EP B1 Publication Date:
24/09/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
17/07/2016
Expiration date:
17/07/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/07/2008
 
 

Name:
Merck Patent GmbH
Address:
Frankfurter Strasse 250, 64293 Darmstadt, Germany (DE)

Inventor

1

Name:
ADAN Jaume
Address:
Spain (ES)

2

Name:
LO Kin-Ming
Address:
United States (US)

3

Name:
MITJANS Francesc
Address:
Spain (ES)

4

Name:
HAHN Diane
Address:
Germany (DE)

5

Name:
GOODMAN Simon
Address:
Germany (DE)

Priority

Priority Number:
07013964
Priority Date:
17/07/2007
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 39/395;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
25/06/2015
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
MARKS & CLERK LLP